MariMed Inc. (MRMD)
OTCMKTS
· Delayed Price · Currency is USD
0.1080
+0.0030 (2.86%)
Apr 25, 2025, 3:58 PM EDT
MariMed Revenue
In the year 2024, MariMed had annual revenue of $157.96M with 6.30% growth. MariMed had revenue of $39.00M in the quarter ending December 31, 2024, with 0.26% growth.
Revenue
157.96M
Revenue Growth
+6.30%
P/S Ratio
0.26
Revenue / Employee
204.09K
Employees
832
Market Cap
41.27M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |
MariMed News
- 13 days ago - Cannabis Stock Gainers And Losers From April 14, 2025 - Benzinga
- 19 days ago - MariMed Announces First Quarter 2025 Earnings Date - GlobeNewsWire
- 20 days ago - MariMed Promotes Ryan Crandall to Chief Commercial Officer - GlobeNewsWire
- 24 days ago - Cannabis Stock Movers For April 3, 2025 - Benzinga
- 24 days ago - MariMed's Betty's Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews - GlobeNewsWire
- 26 days ago - Know A Cannabis Leader Who Stands Out? Nominations Now Open For Bob Fireman Award By Benzinga - Benzinga
- 26 days ago - MariMed Launches Nature's Heritage™ Flower in Illinois - GlobeNewsWire
- 4 weeks ago - Marijuana Stock Movers For March 24, 2025 - Benzinga